Bexagliflozin (Bexacat) side effects in cats

4,053 reports sent to the FDA between 2023 and 2026 involve Bexagliflozin in cats. The most reported problems were ketosis, weight loss, hyperglycaemia. 22% were marked serious, and where it was recorded, signs eased after stopping the medicine in 0% of cases.

4,053Reports
22%Marked serious
74%Only medicine involved
7.4%Recovered
7.8%Died or euthanised
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

About this medicine

Bexagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Bexacat. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Most reported side effects

Share = percentage of this medicine's reports that mention the problem. One report can list several problems.

Reports that it didn't work

Some reports are about the medicine not working (for example a cat still getting fleas or heartworm), not about a side effect.

Didn't stop fleas
1 0.0%

How soon problems started

Same day
368 9.9%
1–2 days
417 11%
3–7 days
854 23%
1–4 weeks
868 23%
Over a month
1,200 32%

Time from the first dose to the first sign, where both dates were reported (3,707 reports).

How the animals did

Recovered
298 7.4%
Still unwell when reported
1,716 42%
Died
69 1.7%
Euthanised
249 6.1%
Not known
1,721 42%

Breeds named most often

Popular breeds appear more often because there are more of them.

Other hormone or endocrine medicines for cats